Erratum for Jacob et al., © 2003 by the American Diabetes Association, Inc. ErrataRaskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM, for the Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin. Diabetes Care 26:20632068, 2003In Fig. 1B of the above-listed article, the solid and dashed lines were inadvertently switched. The corrected figure is shown here.
Jacob G, Costa F, Biaggioni I: Spectrum of autonomic cardiovascular neuropathy in diabetes. Diabetes Care 26:21742180, 2003 In Table 1 of the above-listed article, the mean ± SE upright heart rate for hyperadrenergic patients should have been given as 103 ± 5 bpm.
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||